SPC82
Lomitapíð og öll meðferðarjafngild form þar af eins og verndað er af grunneinkaleyfinu
Status:
VeittApplication date:
21.1.2014Application published:
15.2.2014Grant published:
15.4.2016
Max expiry date:
4.8.2028Next due date:
31.3.2027Medicine name:
LojuxtaMedicine for children:
No
Timeline
Today
21.1.2014Application
15.2.2014Publication
15.4.2016Registration
6.3.2027Expires
Marketing license
IS authorization number:
EU/1/13/851/001-003Date:
28.8.2013
Foreign authorization number:
EU/1/13/851Date:
31.7.2013
Owner
Name:
The Trustees of The University of PennsylvaniaAddress:
3160 Chestnut Street, Suite 200, Philadelphia US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP1725234
Annual fees
Number
Paid
Expires
Payer
Number: 1
Paid: 20.2.2025
Expires: 6.3.2026
Payer: G.H. Sigurgeirsson ehf.
Number: 2
Paid: 19.2.2026
Expires: 6.3.2027
Payer: G.H. Sigurgeirsson ehf.